Stay updated with breaking news from John Farley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Food and Drug Administration announced on Monday it has given full approval for a new preventative injection for infants under age 2 to protect them from contracting respiratory syncytial virus, or RSV.
This fall, parents and pediatricians will have a new option to protect babies from a lung-attacking virus that is the leading cause of hospitalization in infants under a year old
WBAL Radio 1090 AM - New drug to protect babies and toddlers from RSV gets FDA approval
(CNN) — This fall, parents and pediatricians will have a new option to protect babies from a lung-attacking virus that is the leading cause of hospitalization<a class="excerpt-read-more" href="https://whdh.com/news/fda-approves-antibody-to-protect-infants-from-rsv/">Read More</a>
U.S. officials have approved a new long-acting drug to protect babies and toddlers against a respiratory virus that causes thousands of hospitalizations each year. The Food and Drug Administration on Monday approved the injection for infants and children up to 2 years old. It's made by AstraZeneca and is already approved in Canada and Europe. RSV is a cold-like nuisance for most healthy people, but it can be life-threatening for the very young and the elderly. There are no vaccines for babies yet so AstraZeneca's shot is expected to fill a critical need. Pfizer and other companies ar...